Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 18;7(1):20-9.
doi: 10.5312/wjo.v7.i1.20.

Mechanical and cellular processes driving cervical myelopathy

Affiliations
Review

Mechanical and cellular processes driving cervical myelopathy

Roisin T Dolan et al. World J Orthop. .

Abstract

Cervical myelopathy is a well-described clinical syndrome that may evolve from a combination of etiological mechanisms. It is traditionally classified by cervical spinal cord and/or nerve root compression which varies in severity and number of levels involved. The vast array of clinical manifestations of cervical myelopathy cannot fully be explained by the simple concept that a narrowed spinal canal causes compression of the cord, local tissue ischemia, injury and neurological impairment. Despite advances in surgical technology and treatment innovations, there are limited neuro-protective treatments for cervical myelopathy, which reflects an incomplete understanding of the pathophysiological processes involved in this disease. The aim of this review is to provide a comprehensive overview of the key pathophysiological processes at play in the development of cervical myelopathy.

Keywords: Cervical myelopathy; Cervical spine; Neck pain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Degenerative changes that contribute to extrinsic compression of the spinal cord in cervical myelopathy. OPLL: Ossification of the posterior longitudinal ligament.
Figure 2
Figure 2
Determination of the anteroposterior compression ratio in patients with cervical myelopathy. AP = b/a × 100. Reprinted with permission. AP: Anteroposterior compression ratio.
Figure 3
Figure 3
Cellular mechanisms involved in cervical myelopathy. The hypoxia/ischemia cascade results from chronic progressive compression of the cervical spinal cord. This induces extracellular (TNF-α) and intracellular pro-apoptotic pathways (p-53, JNK), induces neuroinflammation and ultimately, neuronal and oligodendrocyte destruction. Additionally, compromise of the BSCB results from ischemia-induced endothelial cell loss. Increased BSCB permeability alters the cellularity of the spinal cord microenvironment and is thought to further potentiate neuroinflammation. These mechanisms contribute to the upper limb dysfunction, spasticity, and gait disturbances observed in human cervical spondylotic myelopathy. BSCB: Blood-spinal cord barrier; TNF-α: Tumor necrosis factor-α.

References

    1. Baptiste DC, Fehlings MG. Pathophysiology of cervical myelopathy. Spine J. 2006;6:190S–197S. - PubMed
    1. Yu WR, Liu T, Kiehl TR, Fehlings MG. Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy. Brain. 2011;134:1277–1292. - PubMed
    1. Toledano M, Bartleson JD. Cervical spondylotic myelopathy. Neurol Clin. 2013;31:287–305. - PubMed
    1. Lee J, Satkunendrarajah K, Fehlings MG. Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes. J Neurotrauma. 2012;29:1012–1027. - PubMed
    1. Broomfield SJ, Da Cruz M, Gibson WP. Cochlear implants and magnetic resonance scans: A case report and review. Cochlear Implants Int. 2013;14:51–55. - PubMed

LinkOut - more resources